Cryptococcus neoformans and Cryptococcus gattii are the causative agents of cryptococcosis. Despite its importance, our knowledge of the epidemiology of cryptococcosis in Japan remains limited. To establish an epidemiological database on cryptococcosis in Japan, we determined the genetic variability of 44 Japanese clinical isolates of C. neoformans (var. grubii: serotype A) by multilocus sequence typing (MLST). The strains were clinically isolated from 1992 to 2011 in 5 different areas of Japan (the Hokkaido region [n ＝ 1], Kanto region [n ＝ 32], Chubu region [n ＝ 1], Kansai region [n ＝ 1], and Kyushu region [n ＝ 9]). According to the method recommended by the International Society for Human and Animal Mycology cryptococcal genotyping working group, 36 isolates (82z) were identified as sequence type (ST)46. The remaining strains belonged to ST45 (n ＝ 1) and ST47 (n ＝ 1), and 6 isolates belonged to novel independent STs. There was little geographic difference in the ST population. Our present data are still limited; however, because most clinical isolates showed the same MLST profile in Japan, applying the current MLST scheme for Cryptococcus may at times be insufficient for investigating the infection route among outbreak cases. To solve this problem, it may be necessary to investigate other gene loci or develop a novel method with greater discriminatory power. However, in cases in which a strain belongs to a minor ST, our data may serve as useful epidemiological information in Japan.
INTRODUCTION
Cryptococcosis is a systemic mycosis caused by the haploid, encapsulated, basidiomycetous yeast Cryptococcus neoformans (serotypes A, D, and AD) and Cryptococcus gattii (serotypes B and C), which are commonly associated with pigeon excreta and plant materials. Cryptococcosis typically involves lung diseases and central nervous system infection. C. neoformans causes approximately 1 million cases of meningitis globally per year in human immunodeficiency virus (HIV)-infected patients, resulting in approximately 624,700 deaths within 3 months after infection (1) .
C. neoformans is presently divided into 2 varieties: C. neoformans var. grubii (serotype A) and C. neoformans var. neoformans (serotype D) (2) . In addition, diploid and aneuploid AD hybrids have been isolated from the environment and patients (3, 4) . C. neoformans var. grubii is responsible for more than 90z cases of cryptococcosis worldwide (5) . The sexual reproduction of Cryptococcus has a two-allele mating system comprising MATa and MATa (6) . The a mating type of C. neoformans is predominant among clinical and environmental isolates (À98z-99.9z) (5) . Mating basically occurs between opposite mating types. Recently, unisexual mating between 2 a cells has been suggested to occur naturally in C. gattii (7) and C. neoformans (8) .
Genotypic analysis such as M13 DNA fingerprinting, amplified fragment length polymorphism, and multilocus sequence typing (MLST) of C. neoformans var. grubii has identified 3 molecular types: VNI, VNII, and VNB (9-13). VNI strains are globally dominant, and VNII isolates are less common. VNB is a novel molecular type discovered as a unique cryptococcal population in Botswana (13) .
Recently, a standardized MLST scheme for C. neoformans and C. gattii has been established by the Cryptococcal Working Group I (Genotyping of C. neoformans and C. gattii) of the International Society for Human and Animal Mycology (ISHAM) to enable global standardization and overcome problems arising from interlaboratory reproducibility (10) . The scheme uses 7 unlinked genetic loci, including the housekeeping genes CAP59, GPD1, LAC1, PLB1, SOD1, and URA5 and the IGS1 region. Based on the ISHAM scheme, 183 clinical and environmental isolates from Thailand and 77 isolates from the global collection of C. neoformans var. grubii were analyzed, and the MLST database was established (14) . The majority of Thailand isolates exhibit 3 sequence types (STs): ST44 (33z, n ＝ 70), ST45 (43z, n ＝ 78), and ST46 (14z, n ＝ 26). ST44 and ST45 are unique to Thailand, and ST46 has been identified in Thailand and Japan (14) . A recent epidemiological report has shown that 31 of the 35 C. neoformans var. grubii isolates from non-HIV patients in Nagasaki, Japan exhibited the same ST based on MLST using the same 7 loci as those used in the ISHAM scheme (15) .
In Japan, cryptococcosis caused by C. neoformans occurs in all regions. Despite its importance, our knowledge of the epidemiology of cryptococcosis in Japan remains limited. The establishment of an epidemiological database on cryptococcosis in Japan is urgently required to manage epidemics and potential outbreaks of cryptococcosis. In this study, we used MLST, a rapid, reproducible, and discriminatory methodology for genotyping isolates of C. neoformans to investigate the genetic relatedness among isolates from several medical facilities in Japan. The MLST database constructed in this study could be a useful resource for global epidemiologic studies and for the recognition and tracking of the inter or intrahospital spread of C. neoformans.
MATERIALS AND METHODS
Clinical isolates: Forty-four clinical isolates of C. neoformans var. grubii were collected from 11 facilities from 5 regions comprising 8 prefectures in Japan. The regional distribution of the isolates was as follows: 1 clinical isolate was collected from 1 facility in the Hokkaido region, 32 clinical isolates were collected from 5 facilities in the Kanto region, 1 clinical isolate was collected from 1 facility in the Chubu region, 1 clinical isolate was collected from 1 facility in the Kansai region, and 9 clinical isolates were collected from 3 facilities in the Kyushu region (Table 1 , Fig. 1 ). Species identification was initially performed by sequencing internal transcribed spacer (ITS) 1-2 and D1/D2 26S ribosomal DNA (rDNA) sequences.
DNA extraction: The isolates were cultured in liquid yeast extract-peptone-dextrose (YPD) medium at 309 C. DNA was extracted from the collected cells using Dr. GenTLE (TakaraBio, Otsu, Japan). Alternatively, a suspension of freshly grown cells was prepared in lysis buffer (DNeasy kit; QIAGEN, Valencia, Calif., USA) and subjected to mechanical lysis using a Multi-Beads Shocker (Yasui Kikai, Osaka, Japan). DNA was then purified from the lysed cells using the DNeasy kit (QIAGEN) according to the manufacturer's protocol.
Serotype and mating type analysis: The mating type of each isolate was determined by 4 different polymerase chain reaction (PCR) amplification reactions. Primers specific to the MATa or MATa allele of the STE20 locus for either serotype A or D isolates were used, namely primers JOHE7270 and JOHE7272 (aA), JOHE7273/JOHE7275 (aD), JOHE7264/JOHE7265 (aA), and JOHE7267/JOHE7268 (aD), as described previously (16) .
MLST analysis: MLST analysis was essentially performed according to a previously described protocol (10) . Each isolate was PCR amplified in 30 ml of reaction volumes for each of the 7 MLST loci using MightyAmp (TakaraBio). The primers used in this study are the same as a previously described protocol (10) , except that a primer LAC1R2 (5?-TCGGACTA TTAATCTCCAAACTC) was used instead of the primer LAC1R (10) . The PCR reaction procedure included denaturation at 949 C for 2 min, followed by 40 cycles of 949 C for 10 s, 609 C for 15 s, and 689 C for 1 min for all the primers. PCR products were run on 1z agarose gel and purified using the DNA purification kit (TakaraBio). Each locus was subsequently sequenced using the Applied Biosystems 3730 sequencer with the BigDye Terminator cycle sequencing kit v3.1 (Applied Biosystems, Foster City, Calif., USA) or by ordering from FASMAC Co., Atsugi, Japan. Sequences were manually edited using EnzymeX (mekentosj.com). Alleles at each locus were assigned numbers (allele types: ATs) in comparison with those identified in the global collection (13) . All nucleotide sequences obtained in this study, including novel ATs, were deposited in the DNA Data Bank of Japan (DDBJ accession nos. AB744719-AB745026). Each unique allelic profile was concatenated and assigned an ST using the archived online C. neoformans database on MLST.net (http://cneofor mans.mlst.net/) (14) .
Phylogenetic analysis: Evolutionary analyses were performed on concatenated sequences from 7 loci (CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and IGS1) in MEGA5 (17) . The evolutionary history was inferred by the maximum-likelihood method based on the Tamura-Nei model (18) .
RESULTS
All the 44 isolates collected in this study belonged to serotype A and mating type a according to PCR classification. Sequence data were obtained for all the 44 Japanese C. neoformans var. grubii isolates typed at the 7 loci (Table 1 ). The 7 loci yielded 26 ATs (CAP59, 4; GPD1, 3; IGS1, 3; LAC1, 5; PLB1, 4; SOD1, 3; and URA5, 4), 3 of which were novel loci (LAC1, SOD1, and URA5). The novel AT of LAC1 (accession no. AB744879) is the closest to AT 1 (addition of C to AT1), the novel AT of SOD1 (accession no. AB744945) is the closest to AT12 (addition of GGA to AT12), and the novel AT of URA5 (accession no. AB744994) is the closest to AT1 (replacement of A with C).
We identified 9 multilocus STs within the Japanese isolates, consisting of ST45, ST46, ST47, and 6 novel STs. Thirty-six of the 44 isolates belonged to ST46 (81z) ( Table 1 ). The remaining strains belonged to ST45 (n ＝ 1) and ST47 (n ＝ 1), and 6 isolates belonged to novel independent STs. A phylogenetic tree was constructed by the maximum-likelihood method based on a concatenated data set from 7 loci for MLST (Fig. 2) . Among the novel STs, 2 strains (NIIDCr0007 and NIIDCr0018) were located in a different cradle, which indicated the VNII genetic type. The other 42 strains belonged to the VNI type, a major type of C. neoformans.
No clinical isolate belonged to the VNB type.
From a geographic perspective, 27 of 34 isolates (79z) from Eastern Japan, including the Hokkaido, Kanto, and Chubu regions, and 9 of 10 isolates (90z) from Western Japan, including the Kansai and Kyushu regions, belonged to ST46, indicating that there is little geographical bias between Eastern and Western Japan in the contributions of ST46 isolates (Fisher's exact test; P ＝ 0.659).
Two isolates (NIIDCr0007 and NIIDCr0018), which belong to the molecular type VNII, were isolated from the Kanto region of Eastern Japan. Table 1 . 
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DISCUSSION
There are no previous studies of MLST epidemiology by the ISHAM standard method for clinical isolates of C. neoformans var. grubii obtained from multiple facilities in Japan. In this study, we analyzed 44 clinical strains of C. neoformans from 11 facilities. Most isolates were classified as the same ST, ST46 (81z). This result indicates that it may be difficult to predict the origin of potential cryptococcosis outbreaks using the MLST scheme if the isolates belong to ST46. However, STs of other isolates are phylogenetically independent of each other (Fig. 2) , and these minor STs will be useful for global epidemiologic studies, recognition, and tracking the inter or intrahospital spread of C. neoformans in Japan.
A recent epidemiological study has shown that clinical and environmental isolates in Thailand predominantly consist of 3 STs, ST44, ST45, and ST46, accounting for up to 90z of the total isolates investigated (14) , indicating low genetic diversity. In Japan, Mihara et al. (15) has reported that 31 of the 35 isolates in Nagasaki, Japan exhibited ST5. ST46 in this study and ST5 in the study of Mihara et al. are derived from the same nucleotide sequences in the 7 loci. This discrepancy of ST might be due to the MLST database; http://cneoformans.mlst.net and http://mlst.mycology lab.org are used for this study and the study of Mihara et al., respectively. To compare STs in this study with the large-scale investigation by Simwami et al. (14) , we adopted the former database. A Chinese epidemiological study has shown that the majority of C. neoformans isolates exhibited the same ST, in which the nucleotide sequences of 5 loci examined (GPD1, IGS1, LAC1, PLB1, and SOD1) are identical to those of ST46 (19) . Similarly, the nucleotide sequences of all 7 loci in the major ST of clinical isolates in Korea are the same as those of ST46 in this study (20) . Together, ST46, a predominant ST in Japan (determined in this study), has so far been isolated in Thailand, China, Korea, and Japan, which are geographically close to each other, suggesting that ST46 isolates from Asia may have the same origin.
Seven strains from the facility G in the Kyushu region (NIIDCr0034-0040) were isolated within a year (2008) (2009) ). Usually, this facility only diagnoses 1 or 2 cases of cryptococcosis per year. Therefore, the high frequency of cryptococcosis could indicate a possibility of outbreaks occurring in the vicinity of the facility G. MLST analysis of these 7 isolates in this study revealed that 6 isolates belong to ST46. The cases at the facility E in the Kanto region showed similar patterns: 7 strains (NIIDCr0024-0027 and 0030-0032) were isolated in 1 year (2010-2011) and 6 isolates exhibited ST46. Local molecular epidemiology restricted to a small area should be able to indicate that these 2 cases were potential outbreaks; however, using our cryptococcal MLST database, the ST46 strain can be recognized as the predominant strain type that is widespread in Japan. Therefore, the present MLST analysis seems less useful for predicting or tracing the infection route or infection source of cryptococcosis outbreaks in Japan. To investigate the actual origin of these outbreaks, novel epidemiological tools such as multilocus microsatellite typing and whole genome sequencing will be required.
In conclusion, we analyzed clinical isolates of C. neoformans obtained from multiple locations widely distributed in Japan by MLST, a molecular epidemiological method. Most clinical isolates belong to the same ST (ST46), and there is little geographic bias among the areas studied. This database will be useful for public health officials in designing and prioritizing efforts to prevent, diagnose, and treat cryptococcal disease.
